News, stories & events
Universal Specimen Transport Medium for Microbes: Sample Preservation
Introduction: Microbiological research plays a pivotal role in understanding the…
Winner of Biocon Biologics award at C-CAMP
Ruhvenile won the Biocon biologics award out of the 3000 applicants from all over India
Developing Biomedical products with French Company
A collaboration between Ruhvenile Biomedical, India, and RNA Smart Health, Paris, France, aims to develop RNA-based therapeutics to combat COVID-19.
Developing Novel Therapeutics
A team, comprising Arockiasamy Arulandu, Sujatha Sunil, and Alessandro Marcello, together with Ruhvenile Biomedical OPC Pvt. Ltd., India, is working to develop novel therapeutics against COVID-19, through the design and synthesis of small, molecular inhibitors specifically targeting SARS-CoV-2 viral replication.
Indigenous antimicrobial product
Ruhvenile has been extensively screening small organic compounds to identify non-toxic, non-ionic compounds with validated enveloped-viruses deactivation potential. One potent non-toxic, carbohydrate-based compound has been shown to deactivate different viruses.
BiomLife® Launch @ HMCW2023
We’re proud that BiomLife was launched by the secretary of the Department of Biotechnology, making it a significant moment for our team. It’s a testament to our innovative approach to microbiome research.
International Seminar 18 June 2022
Professor Henry Daniell and Professor Thomas Muck were invited to give talks on vaccine development and the application of CRISPR technology.
Startup Meetup 28 may 2022
Ruhvenile Biomedical organized an Innovators Meet for inculcating the necessary orientation among the startups to become successful
Meeting French delegate at IIT Delhi
The Ruhvenile team met the French delegate at IIT Delhi on 6th October and is working with the French company to develop biomedical products.
Happy Birthday
Ruhvenile’s whole team is wishing you the happiest of birthdays